Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.

Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.

OBJECTIVE: The purpose of this study was to examine recent trends in the prescribing of hormone therapy for menopause, tibolone, and bisphosphonate preparations for the prevention or treatment of osteoporosis, in the UK in relation to publication of research evidence on the health effects of hormon...

Descripció completa

Dades bibliogràfiques
Autors principals:	Watson, J, Wise, L, Green, J
Format:	Journal article
Idioma:	English
Publicat:	2007

Ítems similars

Hormone replacement therapy prescribing in menopausal women in the UK: a descriptive study
per: Dana Alsugeir, et al.
Publicat: (2022-12-01)

The Effects of Tibolone on Risk Factors of Cardiovascular Disease in Menopausal Women
per: Saeideh Ziaei, et al.
Publicat: (2010-12-01)

Correction: Hormone replacement therapy prescribing in menopausal women in the UK: a descriptive study
Publicat: (2023-03-01)

Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone
per: Laura Staples, et al.
Publicat: (2017-01-01)

Comparative Efficacy of Tibolone and Classic HRT on the Urinary Complications in Menopausal Women
per: R Maasoumi, et al.
Publicat: (2011-01-01)

Effects of hormone replacement therapy and tibolone on skin thickness and bone in postmenopausal women
per: Demir Berfu, et al.
Publicat: (2006-01-01)

Pharmaceutical care issues encountered by post‐menopausal osteoporotic women prescribed bisphosphonates
per: Lai, Pauline Siew Mei, et al.
Publicat: (2012)

Algorithms for prescribing menopausal hormone therapy in different periods of menopause
per: T.F. Tatarchuk, et al.
Publicat: (2022-08-01)

Non-conventional hormone therapy - Tissue-specific Tibolone-Caution
per: Jyotsna Potdar
Publicat: (2010-01-01)

Prescribing menopausal hormone therapy: an evidence-based approach
per: Sood R, et al.
Publicat: (2014-01-01)

Effects of Tibolone on the Breast of Postmenopausal Women
per: Peng-Hui Wang, et al.
Publicat: (2007-06-01)

Pathogenetic rationale for prescribing menopausal hormone therapy for systemic sclerosis
per: T. S. Panevin, et al.
Publicat: (2022-11-01)

Specifics of prescribing menopausal hormonal therapy in patients with the anamnestic endometriosis
per: M. I. Yarmolinskaya, et al.
Publicat: (2021-01-01)

Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence
per: Maria Garefalakis, et al.
Publicat: (2008-03-01)

Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function
per: Sheng-Mou Hsiao, et al.
Publicat: (2024-06-01)

Menopause and menopausal hormone therapy in women: cardiovascular benefits and risks
per: Anna Svatikova, et al.
Publicat: (2018-01-01)

The Effect of Tibolone on Climacteric Symptoms of Healthy Postmenopausal Women
per: S Moghassemi, et al.
Publicat: (2009-07-01)

Effect of Tibolone on sexual function in healthy postmenopausal women
per: Sedigheh moghassemi (MSc), et al.
Publicat: (2010-01-01)

Comparative safety and efficacy of tibolone and escitalopram in postmenopausal women
per: Rajnish Raj, et al.
Publicat: (2021-01-01)

Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort
per: Green, J, et al.
Publicat: (2010)

Repurposing of Tibolone in Alzheimer’s Disease
per: George E. Barreto
Publicat: (2023-07-01)

Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: Case-control analysis within a UK primary care cohort
per: Green, J, et al.
Publicat: (2010)

Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.
per: Green, J, et al.
Publicat: (2010)

Menopausal hormone therapy and central nervous system tumor risk: Large UK prospective study and meta-analysis.
per: Benson, V, et al.
Publicat: (2014)

Menopausal hormone therapy and risk of gastrointestinal cancer: Nested case-control study within a prospective cohort, and meta-analysis
per: Green, J, et al.
Publicat: (2011)

Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis.
per: Green, J, et al.
Publicat: (2012)

Effects of tibolone on markers of bone metabolic activity in postmenopausal women
per: Marić-Krejović Snežana, et al.
Publicat: (2012-01-01)

Improving the quality of life in menopausal women. An overview of menopausal hormone therapy possibilities
per: О. I. Lisitsyna
Publicat: (2019-10-01)

Hormonal replacement therapy in the quality of sleep in menopausal women
per: Z.Zonobi (M.D), et al.
Publicat: (2000-09-01)

Menopausal hormone therapy and women's health: An umbrella review.
per: Guo-Qiang Zhang, et al.
Publicat: (2021-08-01)

Menopausal hormone therapy and women's health: experts' opinion
per: - -
Publicat: (2018-12-01)

Hand osteoarthritis, menopause and menopausal hormone therapy
per: Watt, F
Publicat: (2015)

Solubility and dissolution studies of tibolone polymorphs
per: Rudy Bonfilio, et al.
Publicat: (2018-03-01)

The Effect of Tibolon on Bone Mineral Density and Calcium Metabolism in Postmenopausal Women
per: Ahmet C. Çalışkan, et al.
Publicat: (2003-03-01)

Trends in thyroid hormone prescribing and consumption in the UK
per: Hickey Janis L, et al.
Publicat: (2009-05-01)

THE EFFECTS OF HORMONAL THERAPY IN MENOPAUSE
per: Eduard Crauciuc, et al.
Publicat: (2018-06-01)

Progestogens in menopausal hormone therapy
per: Małgorzata Bińkowska, et al.
Publicat: (2015-06-01)

Menopausal hormone therapy for women with schizophrenia: what’s stopping us?
per: Reilly, TJ, et al.
Publicat: (2024)

Attitude and knowledge of women about menopause and hormone replacement therapy
per: Roya Faraji, et al.
Publicat: (2014-04-01)

Effect of transdermal hormone therapy on platelet haemostasis in menopausal women
per: Grzegorz Stachowiak, et al.
Publicat: (2015-02-01)